Yuval Harari - BIO VIEW Co-CEO, Director

  CEO
Mr. Yuval Harari no longer serves as Executive Vice President and Director at BioView Ltd, but rather as Executive Vice President, effective January 1, 2016. He held the role of Executive Vice President and Director at the Company since April 7, 2009. Previously he served as Vice President of Product Development at the Company . He is one of the Companys CoFounders. His work experience includes the following roles Software Engineering Manager at Neuromedical Systems Israel and Research Fellow at the IBM Research Lab . He holds a BS degree and a MS degree, both in Computer Science from The Hebrew University of Jerusalem.
Age: 53  CEO Since 2016      
972 73 227 1025  http://www.bioview.com

BIO VIEW Management Efficiency

BIO VIEW has return on total asset (ROA) of (3.69) % which means that it has lost $3.69 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (6.08) %, meaning that it generated substantial loss on money invested by shareholders. BIO VIEW management efficiency ratios could be used to measure how well the company manages its routine affairs as well as how well it operates its assets and liabilities.
The company has accumulated 2.57 M in total debt with debt to equity ratio (D/E) of 11.8, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. BIO VIEW has a current ratio of 2.1, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist BIO VIEW until it has trouble settling it off, either with new capital or with free cash flow. So, BIO VIEW's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BIO VIEW sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BIO VIEW to invest in growth at high rates of return. When we think about BIO VIEW's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 12 records

CEO Since

Uriel RosensheinE SCHNAPP WORKS
1978
Hanan ShahafMAGIC SOFTWARE ENT
2016
Yakov TsaroyaMAGIC SOFTWARE ENT
2006
Shlomo TahanISROTEL LTD
2010
Yacov TsruyaMAGIC SOFTWARE ENT
N/A
Yuval ElgrablyREKAH PHARMA IND
2013
Moshe GezMAGIC SOFTWARE ENT
N/A
Uzi YaariMAGIC SOFTWARE ENT
2015
Guy BernsteinMAGIC SOFTWARE ENT
2010
Yuval BaruchMAGIC SOFTWARE ENT
2012
Lior RavivISROTEL LTD
2010
Arye ElgrablyREKAH PHARMA IND
2015
BioView Ltd. develops, manufactures, and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, and pathology clinical and research laboratories in Israel and internationally. The company was founded in 2000 and is headquartered in Rehovot, Israel. BIO VIEW is traded on Tel Aviv Stock Exchange in Israel. BIO VIEW (BIOV) is traded on Tel Aviv Stock Exchange in Israel and employs 12 people.

BIO VIEW Leadership Team

Elected by the shareholders, the BIO VIEW's board of directors comprises two types of representatives: BIO VIEW inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BIO VIEW. The board's role is to monitor BIO VIEW's management team and ensure that shareholders' interests are well served. BIO VIEW's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BIO VIEW's outside directors are responsible for providing unbiased perspectives on the board's policies.
Elad Kfir, Vice President of Marketing
Eliane Markowitz, External Director
Yuval Harari, Co-CEO, Director
Emmanuel Gill, Chairman of the Board
David Kutas, CEO of BioView Inc - USA and President of BioView Inc - USA
Yacha Sutton, Director
Marina Wolfson, CFO
Alan Schwebel, CEO and Pres
Jackie RosenblumGoren, External Director
Inbal Hillel, Vice President - Operations
Lior Shav, Director
Eliyahu AyalonLanciano, External Director
Warren Esanu, Director

BIO VIEW Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BIO VIEW a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in BIO VIEW without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Optimization Now

   

Portfolio Optimization

Compute new portfolio that will generate highest expected return given your specified tolerance for risk
All  Next Launch Module

Pair Trading with BIO VIEW

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BIO VIEW position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BIO VIEW will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Twitter could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Twitter when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Twitter - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Twitter to buy it.
The correlation of Twitter is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Twitter moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Twitter moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Twitter can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities. You can also try Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.

Other Tools for BIO VIEW Stock

When running BIO VIEW price analysis, check to measure BIO VIEW's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BIO VIEW is operating at the current time. Most of BIO VIEW's value examination focuses on studying past and present price action to predict the probability of BIO VIEW's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move BIO VIEW's price. Additionally, you may evaluate how the addition of BIO VIEW to your portfolios can decrease your overall portfolio volatility.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Money Managers
Screen money managers from public funds and ETFs managed around the world
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Bond Directory
Find actively traded corporate debentures issued by US companies
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go